Liraglutide in patients with non-alcoholic steatohepatitis

February 16, 2016 Glucagon-like peptide 1 (GLP-1) analogues are licensed for type 2 diabetes, but they could also be effective in treating patients with non-alcoholic steatohepatitis. To test this, researchers injected the long-acting GLP-1 analogue liraglutide into...

More support for osteoporosis drugs

February 16, 2016 While use of osteoporosis drugs has dropped significantly in recent years following reports of serious adverse events, some experts say that the benefits of the drugs outweigh the risks for many patients. A recent report in the New England Journal of...

US reaches $8 million settlement with CVS Pharmacy

February 16, 2016 CVS Pharmacy has agreed to pay $8 million to the United States to resolve claims that its pharmacies in Maryland violated the Controlled Substances Act (CSA) by dispensing controlled substances pursuant to prescriptions that were not issued for a...

PPIs linked to risk of dementia

February 16, 2016 A new study shows an association between proton pump inhibitors (PPIs) and an increased risk of dementia among older adults. German researchers conducted a prospective cohort study using observational data on more than 73,600 patients from 2004–11....